Matthew Harms
Associate Professor of Neurology at the CUMC · New York Presbyterian Hospital
Credentials: · · · · · ·
History
Research
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Science · 2015 · 797 citations
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia
Proceedings of the National Academy of Sciences of the United States of America · 2013 · 668 citations
Journal of Neuroscience · 2000 · 582 citations
24 papers
- AP
19 papers
13 papers
13 papers
11 papers
8 papers
8 papers
8 papers
Grants
- 2023–2028
Access for All in ALS (ALL ALS) West Clinical Coordinating Center
National Institute of Neurological Disorders and Stroke · OT2
PI · $76.5M · St. Joseph's Hospital and Medical Center
- 2011–2017
Next Generation Sequencing Approaches for Novel Gene Discovery in ALS
National Institute of Neurological Disorders and Stroke · K08
Contact PI · $787.1K · Columbia University Health Sciences
Clinical trials
- 2018–2027
Amyotrophic Lateral Sclerosis (ALS) Families Project
Principal investigator · Recruiting
Columbia University
- 2016–2022
Genomic Translation for Amyotrophic Lateral Sclerosis Care
Principal investigator · Completed
Columbia University
- 2021–2031
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
Site PI · Recruiting
Target ALS Foundation, Inc.